{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T21:20:48Z","timestamp":1784755248679,"version":"3.55.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.clml.2025.04.013","type":"journal-article","created":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T18:26:48Z","timestamp":1745087208000},"page":"720-729.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Risk Factors for Malignant Progression to Adult-T-Cell Leukemia\/Lymphoma in HTLV-1 Carriers: A Systematic Review of Cohort and Case-Control Studies"],"prefix":"10.1016","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8618-3359","authenticated-orcid":false,"given":"Jose M.","family":"Estrada-Grossmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esteban A.","family":"Alarc\u00f3n-Braga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farley E.","family":"Salazar-Valdivia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abigail S.","family":"Jauregui-Cornejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karlos","family":"Acurio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels","family":"Pacheco-Barrios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3718-5857","authenticated-orcid":false,"given":"Ali","family":"Al-kassab-C\u00f3rdova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Enriquez-Vera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.clml.2025.04.013_bib0001","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1128\/CMR.00063-09","article-title":"Epidemiology, treatment, and prevention of Human T-cell leukemia virus type 1-associated diseases","volume":"23","author":"Gon\u00e7alves","year":"2010","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"10.1016\/j.clml.2025.04.013_bib0002","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S1473-3099(19)30402-5","article-title":"Association between HTLV-1 infection and adverse health outcomes: a systematic review and meta-analysis of epidemiological studies","volume":"20","author":"Schierhout","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.clml.2025.04.013_bib0003","unstructured":"World Health Organization. Human T-lymphotropic virus type 1. 2023 [Accessed February 21, 2024]. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/human-t-lymphotropic-virus-type-1"},{"issue":"6","key":"10.1016\/j.clml.2025.04.013_bib0004","doi-asserted-by":"crossref","first-page":"e1705","DOI":"10.1371\/journal.pntd.0001705","article-title":"Living invisible: HTLV-1-infected persons and the lack of care in public health","volume":"6","author":"Zihlmann","year":"2012","journal-title":"PLOS Negl Trop Dis"},{"key":"10.1016\/j.clml.2025.04.013_bib0005","series-title":"StatPearls","article-title":"Human T-cell lymphotropic Virus","author":"Bryan","year":"2024"},{"issue":"24","key":"10.1016\/j.clml.2025.04.013_bib0006","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1182\/blood-2015-03-632489","article-title":"Treatment and survival among 1594 patients with ATL","volume":"126","author":"Katsuya","year":"2015","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.clml.2025.04.013_bib0007","doi-asserted-by":"crossref","first-page":"342","DOI":"10.3390\/pathogens9050342","article-title":"Antiretroviral therapy in HTLV-1 infection: an updated overview","volume":"9","author":"Marino-Merlo","year":"2020","journal-title":"Pathogens"},{"issue":"23","key":"10.1016\/j.clml.2025.04.013_bib0008","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1182\/blood.2019002665","article-title":"Evolution of retrovirus-infected premalignant T-cell clones prior to adult T-cell leukemia\/lymphoma diagnosis","volume":"135","author":"Rowan","year":"2020","journal-title":"Blood"},{"issue":"19","key":"10.1016\/j.clml.2025.04.013_bib0009","first-page":"2299","article-title":"HTLV-1 persistence and the oncogenesis of adult T-cell leukemia\/lymphoma","volume":"141","author":"Bangham","year":"2023","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.clml.2025.04.013_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.bjid.2021.101594","article-title":"Pathogenesis of HTLV-1 infection and progression biomarkers: an overview","volume":"25","author":"Brites","year":"2021","journal-title":"Braz J Infect Dis"},{"issue":"10","key":"10.1016\/j.clml.2025.04.013_bib0011","doi-asserted-by":"crossref","first-page":"8731","DOI":"10.3390\/ijms24108731","article-title":"CD30 Expression and its functions during the disease progression of adult T-cell leukemia\/lymphoma","volume":"24","author":"Nakashima","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.clml.2025.04.013_bib0012","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"9","key":"10.1016\/j.clml.2025.04.013_bib0013","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"Stang","year":"2010","journal-title":"Eur J Epidemiol"},{"issue":"7","key":"10.1016\/j.clml.2025.04.013_bib0014","first-page":"657","article-title":"A nested case-control study of risk factors for adult T-cell leukemia\/lymphoma among human T-cell lymphotropic virus type-I carriers in Japan","volume":"13","author":"Arisaw","year":"2002","journal-title":"Cancer Causes Control"},{"issue":"6","key":"10.1016\/j.clml.2025.04.013_bib0015","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.1002\/jmv.26510","article-title":"Evaluating mRNA expression of tax, B chain of PDGF and PDGF-\u03b2 receptors as well as HTLV-I proviral load in ATL patients and healthy carriers","volume":"93","author":"Atabati","year":"2021","journal-title":"J Med Virol"},{"issue":"10","key":"10.1016\/j.clml.2025.04.013_bib0016","doi-asserted-by":"crossref","first-page":"3557","DOI":"10.1182\/blood.V92.10.3557.422k09_3557_3561","article-title":"Risk factors for adult T-cell leukemia among carriers of human T-lymphotropic virus type I","volume":"92","author":"Hisada","year":"1998","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.clml.2025.04.013_bib0017","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1182\/blood-2009-12-257410","article-title":"Human T-cell leukemia virus type I (HTLV-1) proviral load and disease progression in asymptomatic HTLV-1 carriers: a nationwide prospective study in Japan","volume":"116","author":"Iwanaga","year":"2010","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.clml.2025.04.013_bib0018","first-page":"1059","article-title":"Smoking is a risk factor for development of adult T-cell leukemia\/lymphoma in Japanese human T-cell leukemia virus type-1 carriers","volume":"27","author":"Kondo","year":"2016","journal-title":"Cancer Causes Control"},{"issue":"18","key":"10.1016\/j.clml.2025.04.013_bib0019","doi-asserted-by":"crossref","first-page":"8253","DOI":"10.7314\/APJCP.2015.16.18.8253","article-title":"Plasma soluble CD30 as a possible marker of adult T-cell leukemia in HTLV-1 carriers: a nested case-control study","volume":"16","author":"Takemoto","year":"2015","journal-title":"Asian Pac J Cancer Prev"},{"issue":"9","key":"10.1016\/j.clml.2025.04.013_bib0020","first-page":"3770","article-title":"Tumor necrosis factor alpha polymorphism associated with increased susceptibility to development of adult T-cell leukemia\/lymphoma in human T-lymphotropic virus type 1 carriers","volume":"61","author":"Tsukasaki","year":"2001","journal-title":"Cancer Res"},{"issue":"15","key":"10.1016\/j.clml.2025.04.013_bib0021","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1182\/bloodadvances.2017005900","article-title":"Clonality of HTLV-1\u2013infected T cells as a risk indicator for development and progression of adult T-cell leukemia","volume":"1","author":"Firouzi","year":"2017","journal-title":"Blood Adv"},{"issue":"6","key":"10.1016\/j.clml.2025.04.013_bib0022","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1002\/ijc.24489","article-title":"Common genetic variants and risk for non-hodgkin lymphoma and adult T-cell lymphoma\/leukemia in Jamaica","volume":"125","author":"Wang","year":"2009","journal-title":"Int J Cancer"},{"issue":"4","key":"10.1016\/j.clml.2025.04.013_bib0023","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/ijc.2910590410","article-title":"Adult T-cell leukemia\/lymphoma: a working point-score classification for epidemiological studies","volume":"59","author":"Levine","year":"1994","journal-title":"Int J Cancer"},{"issue":"8550","key":"10.1016\/j.clml.2025.04.013_bib0024","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S0140-6736(87)92752-8","article-title":"Strongyloides stercoralis as candidate co-factor for HTLV-I-induced leukaemogenesis","volume":"2","author":"Yamaguchi","year":"1987","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.clml.2025.04.013_bib0025","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1442-200X.1989.tb01329.x","article-title":"Milk-borne transmission of HTLV-I as a major route in the endemic cycle","volume":"31","author":"Hino","year":"1989","journal-title":"Pediatr Int"},{"issue":"8","key":"10.1016\/j.clml.2025.04.013_bib0026","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1111\/add.16199","article-title":"Global prevalence of heated tobacco product use, 2015\u201322: A systematic review and meta-analysis","volume":"118","author":"Sun","year":"2023","journal-title":"Addiction"},{"issue":"11","key":"10.1016\/j.clml.2025.04.013_bib0027","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1182\/blood-2010-10-312926","article-title":"The host genomic environment of the provirus determines the abundance of HTLV-1\u2013infected T-cell clones","volume":"117","author":"Gillet","year":"2011","journal-title":"Blood"},{"issue":"19","key":"10.1016\/j.clml.2025.04.013_bib0028","first-page":"2299","article-title":"HTLV-1 persistence and the oncogenesis of adult T-cell leukemia\/lymphoma","volume":"141","author":"Bangham","year":"2023","journal-title":"Blood"},{"issue":"15","key":"10.1016\/j.clml.2025.04.013_bib0029","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1182\/bloodadvances.2017005900","article-title":"Clonality of HTLV-1-infected T cells as a risk indicator for development and progression of adult T-cell leukemia","volume":"1","author":"Firouzi","year":"2017","journal-title":"Blood Adv"},{"issue":"1","key":"10.1016\/j.clml.2025.04.013_bib0030","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12977-019-0504-z","article-title":"Molecular epidemiology, genetic variability and evolution of HTLV-1 with special emphasis on African genotypes","volume":"16","author":"Afonso","year":"2019","journal-title":"Retrovirology"},{"issue":"4","key":"10.1016\/j.clml.2025.04.013_bib0031","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/1097-0215(20010215)91:4<497::AID-IJC1044>3.0.CO;2-A","article-title":"Sex-specific mortality from adult T-cell leukemia among carriers of human T-lymphotropic virus type I","volume":"91","author":"Hisada","year":"2001","journal-title":"Int J Cancer"},{"issue":"2","key":"10.1016\/j.clml.2025.04.013_bib0032","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1086\/498910","article-title":"Human leukocyte antigen concordance and the transmission risk via breast-feeding of human T cell lymphotropic virus type I","volume":"193","author":"Biggar","year":"2006","journal-title":"J Infect Dis"},{"key":"10.1016\/j.clml.2025.04.013_bib0033","article-title":"Biological and clinical relevance of genetic alterations in peripheral T-cell lymphomas","author":"Kataoka","year":"2025","journal-title":"J Jpn Med Asso"},{"issue":"1","key":"10.1016\/j.clml.2025.04.013_bib0034","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s40364-025-00747-5","article-title":"Long-term kinetics of proviral load in HTLV-1 carriers: defining risk for the development of adult T-cell leukemia\/lymphoma","volume":"13","author":"Jimbo","year":"2025","journal-title":"Biomark Res"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265025001442?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265025001442?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T05:06:17Z","timestamp":1758603977000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265025001442"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":34,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S2152265025001442"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2025.04.013","relation":{},"ISSN":["2152-2650"],"issn-type":[{"value":"2152-2650","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk Factors for Malignant Progression to Adult-T-Cell Leukemia\/Lymphoma in HTLV-1 Carriers: A Systematic Review of Cohort and Case-Control Studies","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2025.04.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}